Jci_page_head_homepage_01 Jci_page_head_homepage_02
This page
  • E-mail this article

E-mail this article

Are natural killer cells the key to treating Epstein-Barr virus–associated lymphoproliferative disorders?
Michael J. Robertson
Published in Volume 108, Issue 6
J Clin Invest. 2001; 108(6):801 doi:10.1172/JCI14003
Full text | PDF

Recipient's email

Your name

Your e-mail

Comments

Cancel and return to article
Copyright © 2012 American Society for Clinical Investigation.
The JCI is the publication of the ASCI, an honor society of physician-scientists.
Copying, redistribution, and other usage policies